Literature DB >> 7640348

GM-CSF rapidly primes mice for enhanced cytokine production in response to LPS and TNF.

W H Brissette1, D A Baker, E J Stam, J P Umland, R J Griffiths.   

Abstract

Subcutaneous administration of Granulocyte-macrophage-colony stimulating factor (GM-CSF) to mice enhanced LPS-induced cytokine production in the circulation (TNF, IL-6) and peritoneal cavity (IL-1 beta, IL-6). This effect was induced rapidly (within 1 h) and persisted for 4 h. Mice made leukopenic with cyclophosphamide retained the ability to respond to GM-CSF. In addition, TNF induced IL-6 production was also enhanced. These results demonstrate that GM-CSF has a pronounced priming effect on cytokine producing cells in vivo and raises the possibility that this cytokine may contribute to the pathogenesis of septic shock.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7640348     DOI: 10.1006/cyto.1995.0035

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  14 in total

Review 1.  Immune therapy in sepsis: Are we ready to try again?

Authors:  Roger Davies; Kieran O'Dea; Anthony Gordon
Journal:  J Intensive Care Soc       Date:  2018-04-04

2.  Identification of a non-growth factor role for GM-CSF in advanced atherosclerosis: promotion of macrophage apoptosis and plaque necrosis through IL-23 signaling.

Authors:  Manikandan Subramanian; Edward Thorp; Ira Tabas
Journal:  Circ Res       Date:  2014-10-27       Impact factor: 17.367

Review 3.  The multifaceted effects of granulocyte colony-stimulating factor in immunomodulation and potential roles in intestinal immune homeostasis.

Authors:  Andrew Martins; Jiahuai Han; Sung O Kim
Journal:  IUBMB Life       Date:  2010-08       Impact factor: 3.885

4.  Myeloid-derived suppressor cells and myeloid regulatory cells in cancer and autoimmune disorders.

Authors:  Prince Amoah Barnie; Pan Zhang; Hongxiang Lv; Dan Wang; Xiaolian Su; Zhaoliang Su; Huaxi Xu
Journal:  Exp Ther Med       Date:  2016-12-30       Impact factor: 2.447

5.  Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanisms.

Authors:  A Bergamini; F Bolacchi; B Bongiovanni; M Cepparulo; L Ventura; M Capozzi; C Sarrecchia; G Rocchi
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

Review 6.  G-CSF and GM-CSF in Neutropenia.

Authors:  Hrishikesh M Mehta; Michael Malandra; Seth J Corey
Journal:  J Immunol       Date:  2015-08-15       Impact factor: 5.422

7.  Transgenic mice showing inflammation-inducible overexpression of granulocyte macrophage colony-stimulating factor.

Authors:  B Burke; A Pridmore; N Harraghy; A Collick; J Brown; T Mitchell
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

8.  Proteomic Analysis Reveals Distinct Metabolic Differences Between Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Macrophage Colony Stimulating Factor (M-CSF) Grown Macrophages Derived from Murine Bone Marrow Cells.

Authors:  Yi Rang Na; Ji Hye Hong; Min Yong Lee; Jae Hun Jung; Daun Jung; Young Won Kim; Dain Son; Murim Choi; Kwang Pyo Kim; Seung Hyeok Seok
Journal:  Mol Cell Proteomics       Date:  2015-07-30       Impact factor: 5.911

9.  Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease.

Authors:  A D Cook; E L Braine; I K Campbell; M J Rich; J A Hamilton
Journal:  Arthritis Res       Date:  2001-06-11

10.  A role for the protein tyrosine phosphatase CD45 in macrophage adhesion through the regulation of paxillin degradation.

Authors:  Joëlle St-Pierre; Hanne L Ostergaard
Journal:  PLoS One       Date:  2013-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.